{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:03:24Z","timestamp":1780027404947,"version":"3.53.1"},"reference-count":26,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T00:00:00Z","timestamp":1755388800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T00:00:00Z","timestamp":1755388800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. pediatr. gastroenterol. nutr."],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The coexistence of hepatitis B e antigen (HBeAg) and hepatitis B e antibody (HBeAb) during antiviral therapy is considered atypical in patients with chronic hepatitis B (CHB), and its clinical implications remain inadequately understood, particularly in pediatric patients. This study aimed to investigate the clinical characteristics of this coexistence pattern and its impact on the outcomes of combined antiviral therapy in children with CHB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 254 treatment\u2010na\u00efve children diagnosed with HBeAg\u2010positive CHB were retrospectively enrolled. All patients received combination therapy with entecavir and interferon\u2010alpha\/pegylated\u2010interferon\u2010alpha. Participants were categorized into a coexistence group and a control group based on whether HBeAg and HBeAb coexisted during treatment period. Clinical characteristics and treatment outcomes were compared, and Cox regression analysis was used to evaluate factors influencing the coexistence pattern and its association with antiviral responses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The incidence of HBeAg and HBeAb coexistence during antiviral therapy was 35.43% (90\/254). This pattern was associated with the higher HBV DNA levels (hazard ratio [HR]\u2009=\u20091.25,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.009) at baseline. Notably, children in the coexistence group demonstrated a greater likelihood of achieving HBsAg loss (HR\u2009=\u20092.58,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), HBeAg loss (HR\u2009=\u20092.23,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and HBV\u2010DNA undetectability (HR\u2009=\u20091.42,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.034).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The HBeAg\/HBeAb coexistence pattern is relatively common during antiviral therapy in children and is associated with significantly improved treatment outcomes. These findings highlight the importance of monitoring HBeAg\/HBeAb dynamics and continuing treatment during this critical phase.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/jpn3.70196","type":"journal-article","created":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T12:26:50Z","timestamp":1755433610000},"page":"1251-1259","source":"Crossref","is-referenced-by-count":1,"title":["Coexistence of hepatitis B e antigen and antibody during antiviral treatment predicts better clinical outcomes in children"],"prefix":"10.1002","volume":"81","author":[{"given":"Yingping","family":"Gu","sequence":"first","affiliation":[{"name":"Department of Maternal and Child Health, Xiangya School of Public Health Central South University Changsha China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxian","family":"Ouyang","sequence":"additional","affiliation":[{"name":"Liver Disease Center, Hunan Children's Hospital Changsha China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangjie","family":"Li","sequence":"additional","affiliation":[{"name":"Liver Disease Center, Hunan Children's Hospital Changsha China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Maternal and Child Health, Xiangya School of Public Health Central South University Changsha China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Maternal and Child Health, Xiangya School of Public Health Central South University Changsha China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Maternal and Child Health, Xiangya School of Public Health Central South University Changsha China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Maternal and Child Health, Xiangya School of Public Health Central South University Changsha China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1713-4120","authenticated-orcid":false,"given":"Songxu","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Maternal and Child Health, Xiangya School of Public Health Central South University Changsha China"},{"name":"Key Laboratory of Hepatosplenic Surgery, Ministry of Education The First Affiliated Hospital of Harbin Medical University Harbin China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,8,17]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(19)30042-1"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(23)00074-2"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(23)00197-8"},{"key":"e_1_2_8_5_1","unstructured":"World Health Organization.Global Health Sector Strategy on Viral Hepatitis 2016\u20102021. Towards Ending Viral Hepatitis(2016) https:\/\/iris.who.int\/handle\/10665\/246177"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12550"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1586\/17474124.2.4.553"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-020-06056-4"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29800"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.03.021"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S328714"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2010.01345.x"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13731"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.4238\/gmr16019102"},{"issue":"6","key":"e_1_2_8_15_1","first-page":"7569","article-title":"Clinical prognosis of chronic hepatitis B patients with concurrent HBeAg\/Anti\u2010HBe detection and possible mechanism","volume":"12","author":"Wang RT","year":"2019","journal-title":"Int J Clin Exp Med"},{"issue":"11","key":"e_1_2_8_16_1","first-page":"1778","article-title":"Clinical analysis of chronic hepatitis B with concurrent hepatitis e antigen and antibody during antiviral therapy [in Chinese]","volume":"31","author":"Wang XX","year":"2015","journal-title":"J Pract Med"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v27.i36.6053"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-022-10415-7"},{"issue":"12","key":"e_1_2_8_19_1","first-page":"1309","article-title":"Guidelines for the prevention and treatment of chronic hepatitis B (version 2022)","volume":"30","year":"2022","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-012-1781-9"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/15321819.2023.2168556"},{"issue":"04","key":"e_1_2_8_22_1","first-page":"446","article-title":"Clinical characteristics of chronic hepatitis B with concurrent hepatitis B e antigen and antibody detection during the treatment with interferon alpha [in Chinese]","volume":"13","author":"Zhang J","year":"2013","journal-title":"J Trop Med"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.07.022"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-023-10631-9"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1177\/17562848251318037"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep29605"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.10.027"}],"container-title":["Journal of Pediatric Gastroenterology and Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jpn3.70196","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jpn3.70196","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jpn3.70196","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T03:35:16Z","timestamp":1780025716000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jpn3.70196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,17]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.1002\/jpn3.70196"],"URL":"https:\/\/doi.org\/10.1002\/jpn3.70196","archive":["Portico"],"relation":{},"ISSN":["0277-2116","1536-4801"],"issn-type":[{"value":"0277-2116","type":"print"},{"value":"1536-4801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,17]]}}}